new guidelines for treating latent tuberculosis
July 2000
The CDC just released new guidelines for treating latent tuberculosis.
There are changes in the length of isoniazid therapy...plus some shorter rifampin-based regimens to increase compliance and avoid the risk of hepatotoxicity or neuropathy with isoniazid.
Isoniazid...300 mg/day for 6 to 9 months. Give INH for the full 9 months to children...or patients with HIV or previous TB.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote